Pfizer’s first quarter results drew a positive market response as management emphasized margin improvement and disciplined ...

Pfizer (NYSE:PFE) stock is a biopharmaceutical firm that had a magnificent breakout in 2021 as the worst of the pandemic sent ...

Recipients of the Pfizer mRNA vaccine experienced more all-cause deaths within the first 100 days post-vaccination than ...

Pfizer’s 7%+ yield is tempting, but rising political, regulatory, and business risks threaten its stability and growth ...

BioNTech said in 2022 that it faced “threats of a groundless patent infringement suit” from a company that was “unable to ...

A major revision to the schedule for COVID-19 vaccines comes on the heels of Sen. Ron Johnson’s, R-Wis., issuance of an ...

The American College of Obstetricians and Gynecologists is urging insurers to continue covering vaccinations during pregnancy ...

Pfizer is undervalued as markets fixate on its patent cliff, overlooking strong cash flows, pipeline upside, and a 7% yield.

Now that Covid vaccines are no longer recommended for healthy children and pregnant people, boosters could be a lot more ...

A new COVID-19 variant spreading in some parts of the world has been nicknamed "razor blade throat" because of its painful ...

Researchers examined which participants developed kidney disease severe enough to require a dialysis known as continuous ...

A new study from UCLA Health suggests COVID-19 vaccines may protect patients from severe kidney damage. The study found ...